Skip to main content

RETRACTION article

Front. Immunol., 21 May 2024
Sec. Inflammation
Volume 15 - 2024 | https://doi.org/10.3389/fimmu.2024.1430750

Retraction: MicroRNA-200a inhibits inflammation and atherosclerotic lesion formation by disrupting EZH2-mediated methylation of STAT3

This article is a retraction of:

  1. RETRACTED: MicroRNA-200a Inhibits Inflammation and Atherosclerotic Lesion Formation by Disrupting EZH2-Mediated Methylation of STAT3

    1. Read original article
Frontiers Editorial Office* Frontiers Editorial Office*

    A Retraction of the Original Research Article
    MicroRNA-200a inhibits inflammation and atherosclerotic lesion formation by disrupting EZH2-mediated methylation of STAT3

    By Wang J, Li P, Xu X, Zhang B and Zhang J (2020). Front. Immunol. 11:907. doi: 10.3389/fimmu.2020.00907

    Please, find the retraction statement below:

    “Following publication, concerns were raised regarding the integrity of the images in the published figures OR regarding the validity of the data presented in the article. The authors failed to provide the raw data or a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers’ policies. Given the concerns about the validity of the data, and the lack of raw data, the editors no longer have confidence in the findings presented in the article.

    This retraction was approved by the Chief Executive Editor of Frontiers. The authors received a communication regarding the retraction and had a chance to respond. This communication has been recorded by the publisher.”.

    Citation: Frontiers Editorial Office (2024) Retraction: MicroRNA-200a inhibits inflammation and atherosclerotic lesion formation by disrupting EZH2-mediated methylation of STAT3. Front. Immunol. 15:1430750. doi: 10.3389/fimmu.2024.1430750

    Received: 10 May 2024; Accepted: 10 May 2024;
    Published: 21 May 2024.

    Approved by:

    Frontiers Editorial Office, Frontiers Media SA, Switzerland

    Copyright © 2024 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    *Correspondence: Frontiers Editorial Office, research.integrity@frontiersin.org

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.